Hello, It’s been a long, exciting albeit tiring week for the healthcare team as we made our way around San Francisco’s Union Square during the J.P. Morgan Healthcare Conference. Hills were climbed, cricket tacos consumed, and healthcare discussed at length. Many, many stories ahead from those conversations. But to start, […]
On Monday, a new drug for depression got a big lift from positive clinical trial results. Stocks surged on the news. The drug is made by Sage Therapeutics, a Cambridge-based pharmaceutical company that focuses on brain disorders. Nearly all existing antidepressants, from Celexa to Zoloft, work on the brain’s serotonin […]
Investors’ excitement about a promising new drug for depression reached a fever pitch last week when the CEO of the company behind it likened the drug to an antibiotic. Sage Therapeutics’ CEO Jeff Jonas said the drug, called SAGE-217, could be administered like a two-week course of antibiotics, which are […]
A new treatment for postpartum depression just...